Avalo Therapeutics, Inc.
AVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534120
In the last 90 days, Avalo Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $1.31B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Avalo Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 66
- +30 vs. Q2 2025
- Shares held
- 15.3M
- +7.47M (+95.3%) vs. Q2 2025
- Total value
- $194.7M
- +$155.5M (+397.4%) vs. Q2 2025
- New holders
- 32
- 15 more added
- Sold out
- 2
- 8 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $1.31B |
| Q1 2026 | 97 | $469.6M |
| Q4 2025 | 84 | $361.1M |
| Q3 2025 | 66 | $194.7M |
| Q2 2025 | 36 | $39.1M |
| Q1 2025 | 34 | $66.1M |
| Q4 2024 | 33 | $56.0M |
| Q3 2024 | 29 | $63.2M |
| Q2 2024 | 21 | $9.62M |
| Q1 2024 | 18 | $1.90M |
| Q4 2023 | 12 | $209.4K |
| Q3 2023 | 28 | $158.9K |
| Q2 2023 | 26 | $862.7K |
| Q1 2023 | 32 | $16.0M |
| Q4 2022 | 28 | $28.0M |
| Q3 2022 | 27 | $18.4M |
| Q2 2022 | 54 | $34.7M |
| Q1 2022 | 71 | $56.2M |
| Q4 2021 | 75 | $136.0M |
| Q3 2021 | 77 | $175.5M |
| Q2 2021 | 71 | $218.1M |
| Q1 2021 | 70 | $180.4M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Avalo Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avion Wealth | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 1 | $13 | 0.00% | 00.0% | Unchanged |
| Key Financial Inc | 1 | $13 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 1 | $13 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2 | $18 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 5 | $64 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 10 | $127 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 23 | $292 | 0.00% | +1+4.5% | Added |
| Tower Research Capital LLC (TRC) | 26 | $330 | 0.00% | +26 | New |
| Group One Trading, L.P. | 281 | $3.57K | 0.00% | +280+28,000.0% | Added |
| Citigroup Inc | 400 | $5.08K | 0.00% | +400 | New |
| Simplex Trading, LLC | 748 | $9.00K | 0.00% | +748 | New |
| PFS Partners, LLC | 1,000 | $12.7K | 0.01% | +1,000 | New |
| JPMorgan Chase & Co | 1,573 | $20.0K | 0.00% | +1,499+2,025.7% | Added |
| BIT Capital GmbH | 1,929 | $24.5K | 0.00% | +1,929 | New |
| Barclays PLC | 9,346 | $118.8K | 0.00% | +9,346 | New |
| Dimensional Fund Advisors LP | 11,215 | $143.2K | 0.00% | +11,215 | New |
| XTX Topco Ltd | 13,950 | $177.3K | 0.01% | +13,950 | New |
| Northern Trust Corp | 18,575 | $236.1K | 0.00% | −4,098−18.1% | Reduced |
| Prelude Capital Management, LLC | 24,628 | $313.0K | 0.02% | +24,628 | New |
| HighVista Strategies LLC | 27,778 | $353.1K | 0.09% | +27,778 | New |
| Birchview Capital, LP | 31,000 | $394.0K | 0.30% | +31,000 | New |
| ADAR1 Capital Management, LLC | 32,393 | $411.7K | 0.04% | −72,337−69.1% | Reduced |
| Landscape Capital Management, L.L.C. | 33,337 | $423.7K | 0.03% | +33,337 | New |
| Walleye Capital LLC | 44,743 | $568.7K | 0.00% | +24,130+117.1% | Added |
| UBS Group AG | 45,208 | $574.6K | 0.00% | −38,516−46.0% | Reduced |
| State Street Corp | 45,454 | $577.7K | 0.00% | +45,454 | New |
| Susquehanna International Group, LLP | 47,398 | $602.4K | 0.00% | +47,398 | New |
| Two Sigma Investments, LP | 49,242 | $625.9K | 0.00% | +36,353+282.0% | Added |
| Quadrature Capital Ltd | 54,999 | $695.7K | 0.01% | +44,023+401.1% | Added |
| Marshall Wace, LLP | 56,009 | $711.9K | 0.00% | +56,009 | New |
| Sio Capital Management, LLC | 72,173 | $917.3K | 0.23% | 00.0% | Unchanged |
| Standard Life Aberdeen plc | 72,800 | $925.3K | 0.00% | +72,800 | New |
| DLD Asset Management, LP | 75,000 | $953.3K | 0.12% | +75,000 | New |
| Cantor Fitzgerald, L. P. | 85,247 | $1.08M | 0.02% | +85,247 | New |
| Adviser Investments LLC | 86,516 | $1.10M | 0.01% | −174,500−66.9% | Reduced |
| Renaissance Technologies LLC | 98,700 | $1.25M | 0.00% | +98,700 | New |
| Patient Square Capital LP | 100,000 | $1.27M | 0.34% | +100,000 | New |
| Exome Asset Management LLC | 100,036 | $1.27M | 0.84% | +100,036 | New |
| Geode Capital Management, LLC | 104,189 | $1.33M | 0.00% | −6,271−5.7% | Reduced |
| Boxer Capital Management, LLC | 125,000 | $1.59M | 0.51% | +125,000 | New |
| Millennium Management LLC | 137,431 | $1.75M | 0.00% | +137,431 | New |
| Perceptive Advisors LLC | 139,667 | $1.78M | 0.05% | 00.0% | Unchanged |
| Deep Track Capital, LP | 144,600 | $1.84M | 0.05% | −422,503−74.5% | Reduced |
| BlackRock, Inc. | 154,251 | $1.96M | 0.00% | −1,648−1.1% | Reduced |
| Ikarian Capital, LLC | 159,777 | $2.03M | 0.46% | +124,477+352.6% | Added |
| Ally Bridge Group (NY) LLC | 178,100 | $2.26M | 1.90% | +178,100 | New |
| Superstring Capital Management LP | 188,080 | $2.39M | 2.36% | +188,080 | New |
| Ameriprise Financial Inc | 213,572 | $2.71M | 0.00% | +213,572 | New |
| Boothbay Fund Management, LLC | 228,297 | $2.90M | 0.07% | +216,976+1,916.6% | Added |
| Adage Capital Partners GP, L.L.C. | 258,769 | $3.29M | 0.01% | +258,769 | New |
| Velan Capital Investment Management LP | 263,642 | $3.35M | 3.15% | +108,670+70.1% | Added |
| Citadel Advisors LLC | 481,669 | $6.12M | 0.00% | +481,669 | New |
| Commodore Capital LP | 483,000 | $6.14M | 0.30% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 483,000 | $6.14M | 0.30% | 00.0% | Unchanged |
| Bank of America Corp | 605,842 | $7.70M | 0.00% | +199,271+49.0% | Added |
| Ra Capital Management, L.P. | 662,968 | $8.43M | 0.10% | −270,005−28.9% | Reduced |
| Vanguard Group Inc | 692,637 | $8.80M | 0.00% | +525,696+314.9% | Added |
| Silverarc Capital Management, LLC | 720,922 | $9.16M | 1.33% | +720,922 | New |
| Balyasny Asset Management LLC | 817,436 | $10.4M | 0.02% | +817,436 | New |
| Caligan Partners LP | 833,333 | $10.6M | 1.47% | +833,333 | New |
| Affinity Asset Advisors, LLC | 1,006,217 | $12.8M | 1.19% | +398,345+65.5% | Added |
| Point72 Asset Management, L.P. | 1,053,983 | $13.4M | 0.03% | +1,053,983 | New |
| Nantahala Capital Management, LLC | 1,235,000 | $15.7M | 0.97% | +240,000+24.1% | Added |
| OrbiMed Advisors LLC | 1,349,300 | $17.1M | 0.41% | +382,300+39.5% | Added |
| BVF Inc | 1,355,256 | $17.2M | 0.70% | +327,207+31.8% | Added |
| Allostery Investments LP | 0 | $0 | 0.00% | −9,000−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |